Number and Migratory Activity of Circulating Endothelial Progenitor Cells Inversely Correlate With Risk Factors for Coronary Artery Disease

By M. Vasa, S. Fichtlscherer, Alexandra Aicher, K. Adler, C. Urbich, H. Martin, A. Zeiher, Stefanie Dimmeler. Circulation Research, 2001

2,491 citations recorded by the source corpus.

Subfields: Cancer Research, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/5eca27f33bc6b051b3e7e9ac84b9bc41f4c0e13b

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cancer Research

1. Stefanie Dimmeler
2. A. Zeiher
3. C. Kevil
4. Alexandra Aicher
5. S. Bir
6. G. Kolluru
7. C. Heeschen
8. C. Urbich

In Molecular Biology

1. Stefanie Dimmeler
2. A. Zeiher
3. C. Urbich
4. C. Heeschen
5. Alexandra Aicher
6. M. Schneider
7. C. Kevil
8. S. Bir

Citations in the corpus

• Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. (2004, neutral): “Indeed, studies have demonstrated that, in patients with cardiovascular risk factors, the number of EPCs that can be isolated from peripheral blood is reduced (6) and EPC function is impaired (7,8).”
• Endothelial Dysfunction and Diabetes: Effects on Angiogenesis, Vascular Remodeling, and Wound Healing (2012, background): “There are numerous studies that have demonstrated, in patients with diabetes and cardiovascular disease, that the number of EPCs from peripheral blood is reduced and EPC function impaired [73, 88, 236, 237].”
• Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. (2005, methodology): “The endothelial phenotype of human peripheral bloodderived EPC was confirmed by expression of KDR, von Willebrand factor, CD146, VE-cadherin, and eNOS in previous studies [9,29].”
• Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. (2005, neutral): “This finding apparently contradicts other data in the literature, but it should be noted that Vasa et al. (10) reported a 40% reduction of EPCs in a cohort of patients with CAD, compared with age-matched healthy volunteers; however, their CAD group included not only patients with stable disease, but ”
• Pharmacological and Clinical Aspects of Heme Oxygenase (2008, neutral): “A higher serum bilirubin level is related to a decrease in lipid peroxidation and is associated with a decrease in the risk for coronary artery disease in humans (Sano et al., 1985; Vasa et al., 2001).”
• Adiponectin Regulation and Function (2018, neutral): “EPCs are negatively correlated with the severity of atherosclerosis (159, 337, 397).”